NICE has set a new ... s cholesterol levels were lowered. Earlier this year, NICE also introduced guidance to encourage the use of statins, lowering the threshold for prescribing these drugs ...
Cholesterol is a vital substance in our bodies. It helps with many important functions, such as building cells and producing ...
Esperion (ESPR) has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications ...
Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...
News Medical on MSN4mon
Study identifies non-statin cholesterol drugs with potential to lower liver cancer riskPast studies have suggested that taking cholesterol-lowering statin drugs may lower individuals' risk of developing liver ...
The body needs some cholesterol to maintain good health. But for those who need to reduce the risk of a heart attack or stroke, statin drugs lower ... analysis in the New England Journal of ...
The seniors in the study were switched to non-statin cholesterol medications ... Bempedoic acid (Nexlotol) is a new cholesterol medicine with much less risk of muscle damage, but I couldn ...
Overall, a 20% decrease in LDL cholesterol was seen. Participants reported that they would have found more information on drug interactions ... make statins unavailable to non-insured or indigent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback